GAITHERSBURG, Md., April 02, 2026 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS), a global life sciences leader with biodefense and medical countermeasures products, announced today that members of its products business, medical affairs, government…
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
Emergent BioSolutions announced participation in international preparedness conferences without disclosing specific cybersecurity vulnerabilities or product risks. The lack of transparency raises concerns about potential undisclosed vulnerabilities in their biodefense and medical countermeasures products. Affected stakeholders include government agencies, healthcare providers, and defense sectors relying on Emergent BioSolutions' products.